Literature DB >> 18035477

Forkhead transcription factor FOXO subfamily is essential for reactive oxygen species-induced apoptosis.

Tomohiro Nakamura1, Kazuichi Sakamoto.   

Abstract

Intracellular accumulation of reactive oxygen species is implicated in the pathogenesis of cancer and other diseases by disturbing proper cell cycle control or cell survival. Here, we show that the expression and phosphorylation of FOXO is drastically affected by H(2)O(2) treatment, resulting in drastic induction of luteal cell apoptosis. Western blot analysis revealed that FOXO1a accumulated preferentially in the nucleus upon ROS stimuli, resulting in the transactivation of IRS promoter activity driven by H(2)O(2)-activated FOXO1a. Because ROS-induced cell death was suppressed by co-transfection of a FOXO3a mutant that lacks the activation-domain of transcription, transactivation of pro-apoptotic genes by FOXO was necessary to cause ROS-induced apoptosis. In fact, expression of several pro-apoptotic genes, such as Bim and BCL-6 was induced in H(2)O(2)-stimulated cells, and was blocked by co-transfection of dominant-negative type FOXO3a mutant. These findings indicate that FOXO is a key regulator of ROS-induced apoptosis in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18035477     DOI: 10.1016/j.mce.2007.10.007

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  42 in total

Review 1.  The "O" class: crafting clinical care with FoxO transcription factors.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Jinling Hou; Yan Chen Shang
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

2.  The effects of silencing of PI3K p85α on 5-FU-induced colorectal cancer cells apoptosis.

Authors:  Yan Sun; Hua Tian; Lin Wang; Hui Yang
Journal:  Med Oncol       Date:  2013-08-29       Impact factor: 3.064

Review 3.  A "FOXO" in sight: targeting Foxo proteins from conception to cancer.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang; Jinling Hou
Journal:  Med Res Rev       Date:  2009-05       Impact factor: 12.944

Review 4.  A fork in the path: Developing therapeutic inroads with FoxO proteins.

Authors:  Kenneth Maiese; Jinling Hou; Zhao Zhong Chong; Yan Chen Shang
Journal:  Oxid Med Cell Longev       Date:  2009 Jul-Aug       Impact factor: 6.543

Review 5.  Therapeutic promise and principles: metabotropic glutamate receptors.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang; Jinling Hou
Journal:  Oxid Med Cell Longev       Date:  2008 Oct-Dec       Impact factor: 6.543

Review 6.  New strategies for Alzheimer's disease and cognitive impairment.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Jinling Hou; Yan Chen Shang
Journal:  Oxid Med Cell Longev       Date:  2009 Nov-Dec       Impact factor: 6.543

7.  Activation of the AMPK-FOXO3 pathway reduces fatty acid-induced increase in intracellular reactive oxygen species by upregulating thioredoxin.

Authors:  Xiao-Nan Li; Jun Song; Lin Zhang; Scott A LeMaire; Xiaoyang Hou; Cheng Zhang; Joseph S Coselli; Li Chen; Xing Li Wang; Yun Zhang; Ying H Shen
Journal:  Diabetes       Date:  2009-07-10       Impact factor: 9.461

8.  Leptin administration downregulates the increased expression levels of genes related to oxidative stress and inflammation in the skeletal muscle of ob/ob mice.

Authors:  Neira Sáinz; Amaia Rodríguez; Victoria Catalán; Sara Becerril; Beatriz Ramírez; Javier Gómez-Ambrosi; Gema Frühbeck
Journal:  Mediators Inflamm       Date:  2010-06-30       Impact factor: 4.711

Review 9.  Foxo3a: an integrator of immune dysfunction during HIV infection.

Authors:  Julien van Grevenynghe; Rafael A Cubas; Sandrina DaFonseca; Talibah Metcalf; Cecile L Tremblay; Lydie Trautmann; Rafick-Pierre Sekaly; John Schatzle; Elias K Haddad
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-27       Impact factor: 7.638

Review 10.  Erythropoietin, forkhead proteins, and oxidative injury: biomarkers and biology.

Authors:  Kenneth Maiese; Jinling Hou; Zhao Zhong Chong; Yan Chen Shang
Journal:  ScientificWorldJournal       Date:  2009-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.